Abstract
Isocitrate dehydrogenase 2 (IDH2) mutations have been reported in gliomas, osteosarcomas, cartilaginous tumors, giant cell tumors of bone, and acute myeloid leukemias. Although IDH2 catalyzes the oxidative carboxylation of isocitrate to α-ketoglutarate (α-KG) in mitochondria, mutated IDH2 proteins possess the ability to change α-KG into the oncometabolite R(-)-2-hydroxyglutarate (2-HG). To date, several monoclonal antibodies (mAbs) specific for IDH2 mutations have been established, such as KMab-1 against IDH2-R172K, MMab-1 against IDH2-R172M, and WMab-1 against IDH2-R172W. Although a multi-specific mAb MsMab-1 reacted with IDH2-R172G and IDH2-R172S, a mono-specific mAb against IDH2-R172S has not been established. In this study, we established a novel mAb SMab-2, which recognizes IDH2-R172S but not with wild type IDH2 in ELISA. Although SMab-2 reacted with both IDH1-R132S and IDH2-R172S expressed in Escherichia coli, it reacted with only IDH2-R172S expressed in U-2 OS osteosarcoma cells. Furthermore, SMab-2 recognized endogenous IDH2-R172S protein expressed in SW1353 chondrosarcoma cells in Western blot and immunocytochemical analyses. SMab-2 is expected to be useful for diagnosis of IDH2-R172S-bearing tumors.
References
Sep 19, 2006·Biochemical and Biophysical Research Communications·Yukinari KatoMotoki Osawa
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Aug 7, 2009·The New England Journal of Medicine·Elaine R MardisTimothy J Ley
Jan 29, 2010·The New England Journal of Medicine·Anthony Green, Philip Beer
Jun 23, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter PaschkaKonstanze Döhner
Mar 1, 2011·Biochemical and Biophysical Research Communications·Mika Kato KanekoYukinari Kato
Nov 1, 2011·Analytical Chemistry·Benjamin J HindsonBill W Colston
Nov 8, 2011·Nature Genetics·Twinkal C PansuriyaJudith V M G Bovée
Nov 8, 2011·Nature Genetics·M Fernanda AmaryAdrienne M Flanagan
Jan 13, 2012·Science Translational Medicine·Ovidiu C AndronesiA Gregory Sorensen
Feb 2, 2013·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Brendan PangMarina N Nikiforova
Feb 5, 2013·Biochemical and Biophysical Research Communications·Mika Kato KanekoYukinari Kato
Mar 26, 2013·Biochemical and Biophysical Research Communications·Yukinari Kato, Mika Kato Kaneko
Jun 21, 2013·The Tohoku Journal of Experimental Medicine·Mika Kato KanekoYukinari Kato
Dec 18, 2013·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Satoshi OgasawaraYukinari Kato
Dec 19, 2013·Cancer Science·Kunihiko MoriyaYukinari Kato
Jan 10, 2014·Cancer Medicine·Xing LiuMichiaki Takagi
Feb 1, 2014·Protein Expression and Purification·Yuki FujiiJunichi Takagi
Apr 22, 2014·Brain Tumor Pathology·Hideyuki AritaKoichi Ichimura
Jun 6, 2014·Cancer Science·Mika Kato KanekoYukinari Kato
Jul 11, 2014·Brain Tumor Pathology·Hideyuki AritaKoichi Ichimura
Oct 18, 2014·Brain Tumor Pathology·Yukinari Kato
Citations
Oct 28, 2016·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Satoshi OgasawaraYukinari Kato
Jan 6, 2017·PloS One·Daniel SalinasRonald K June
Mar 25, 2017·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Yuki FujiiYukinari Kato